Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LP-98 Injection in Healthy Subjects
Clinical trial NCT05933824 · COMPLETED
Trial details
- NCT number
- NCT05933824
- Sponsor
- Shanxi Kangbao Biological Product Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-13
- Primary completion
- 2024-04-12
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.